文献速递神经头颈MR

MRI深度学习术前预测垂体神经内分泌肿瘤分子亚型

Deep Learning Based on Magnetic Resonance Imaging for Preoperative Prediction of Pituitary Neuroendocrine Tumors Subtypes.
PubMed 文献 · Acad Radiol · 2026-09-14

本研究回顾性纳入两个中心共888例病理确诊的垂体神经内分泌肿瘤患者,按SF1、PIT1、TPIT转录因子表达分为四个分子亚型。利用术前多序列MRI训练YOLOv11模型进行亚型分类,并通过内部、时间外部及多中心验证评估性能。结果显示矢状位增强T1WI预测最佳(mAP50-95为0.901),提示MRI深度学习可术前无创预测亚型。

要点

  • 矢状位增强T1WI是预测垂体神经内分泌肿瘤分子亚型的最优序列
  • 深度学习模型可区分PIT1、TPIT、SF1谱系及无明确细胞谱系四类亚型
  • 该模型有望在术前为个体化治疗决策提供影像学依据

核心结论

  • 基于MRI的深度学习模型能够在回顾性队列中准确进行垂体神经内分泌肿瘤术前分子亚型分类
  • 矢状位增强T1WI序列预测性能最佳,mAP50-95达0.901;冠状位T2WI序列表现相对较差,mAP50-95为0.756

研究设计与样本

  • 纳入患者平均年龄54.32岁,女性占52.9%
  • 所有患者术前均行MRI检查,包括冠状位T1WI、T2WI、增强T1WI序列及矢状位T1WI、增强T1WI序列
  • 采用YOLOv11模型,以单一或联合序列训练实现亚型分类
  • 通过内部验证、时间外部验证及多中心验证评估模型性能,评价指标包括mAP、精确率、召回率和F1分数

诊断标准与关键数值

  • 患者按SF1、PIT1、TPIT转录因子表达情况分为PIT1谱系、TPIT谱系、SF1谱系及无明确细胞谱系四组
  • 矢状位增强T1WI序列mAP50-95为0.901,在所有序列中预测性能最佳
  • 冠状位T2WI序列mAP50-95为0.756,预测性能相对较差
  • 模型在内部验证集、时间外部测试集和多中心验证队列中均能有效区分四种分子亚型

临床应用与阅片要点

  • 阅片时可优先关注矢状位增强T1WI序列特征,其对垂体神经内分泌肿瘤分子亚型的预测价值最高
  • 深度学习模型有望在术前报告环节辅助判断肿瘤分子谱系,为治疗策略选择提供参考

局限性

  • 研究为回顾性设计,文中提出需经前瞻性验证后进一步研究

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Molecular subtyping of pituitary neuroendocrine tumors (PitNETs [pituitary adenoma]) guides treatment but requires postoperative pathology. This study aimed to develop a deep learning model for preoperative noninvasive prediction of PitNET subtypes using magnetic resonance imaging (MRI).

MATERIALS AND METHODS: This study retrospectively enrolled patients with pathologically confirmed PitNETs from two centers. Patients were classified into four groups based on the expression of the SF1, PIT1, and TPIT transcription factors as follows: PIT1 lineage, TPIT lineage, SF1 lineage, and no distinct cell lineage. All patients underwent preoperative MRI examinations comprising coronal T1-weighted (T1WI), T2-weighted (T2W1), and contrast-enhanced T1WI sequences, as well as sagittal T1WI and contrast-enhanced T1WI sequences. The YOLOv11 model was trained using either single or combined sequences to achieve subtype classification. Performance was evaluated via internal, temporal external, and multicenter validation using mean average precision (mAP), precision, recall, and F1-score.

RESULTS: This retrospective study included a total of 888 patients enrolled between January 2021 and December 2025, with a mean age of 54.32 years; 52.9% of the patients were female. The model performed robustly in the internal validation set, temporal external test set, and multicenter validation cohort, effectively distinguishing among the four molecular subtypes. Among these, sagittal contrast-enhanced T1WI sequences yielded the best predictive results (mAP50-95: 0.901), while coronal T2WI sequences performed relatively poorly (mAP50-95: 0.756).

CONCLUSION: MRI-based deep learning enables accurate preoperative PitNET subtyping in retrospective cohorts, warranting investigation as a tool to aid personalized management following prospective validation.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Yang, Xiong, Yu, et al. Deep Learning Based on Magnetic Resonance Imaging for Preoperative Prediction of Pituitary Neuroendocrine Tumors Subtypes. Acad Radiol. 2026. PMID: 42736093. doi:10.1016/j.acra.2026.08.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。